US:
UK:
JAPAN:
- Report code : CMI-243
- Industry : Pharmaceutical
- Published On : Mar 2019
- Pages : 153 Pages
- Format :
Press Release: Pyrogen Testing Market to Surpass US$ 1.9 Billion by 2026
Press Release: Pyrogen Testing Market to Surpass US$ 1.9 Billion by 2026
Global Pyrogen Testing Market – A Novel Approach for Detecting Pyrogen Contamination
Pyrogen testing plays a major role in advanced healthcare, as it shows the presence of pyrogen in an organism that causes fever. Pyrogen can be found in lipopolysaccharides and lepoteichoic acid. Contaminated pyrogenic products can cause harmful effects such as fever in human body.
The global pyrogen testing market size was valued at US$ US$ 689.9 million in 2017, and is expected to exhibit a CAGR of 12.4% over the forecast period (2018 – 2026).
Figure 1. Global Pyrogen Testing Market Value (US$ Mn), by Region, 2017
Source: Coherent Market Insights Analysis
Increasing demand for testing of pyrogen contamination in medical devices and drugs is expected to propel growth of the pyrogen testing market
Pyrogen testing is used in detection of pyrogen contamination in pharmaceutical dosage forms and medical devices. Pyrogen contaminated injections post administration can cause temperature dysregulation (fever), bodyache, inflammation, shock, multiorgan failure, and other life threatening problems.
Moreover, increasing research and development of therapeutic drugs and medical devices is propelling growth of the pyrogen testing market over the forecast period. According to the United Nations Educational, Scientific and Cultural Organization (UNESCO), November 2016, an estimated US$ 1.7 trillion of global spending in research and development for various medical applications. Moreover, the U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER), has approved around 59 novel drugs in 2018 compared to 46 approvals of new molecule entities in 2017.
Figure 2. Global Pyrogen Testing Market Share (%), by Test Type, 2018 and 2026
Source: Coherent Market Insights Analysis
Increasing research and development in healthcare sector in North America is expected to bolster the market growth
North America holds dominant position in the pyrogen testing market, owing to high prevalence of cardiovascular disease. According to the European Federation of Pharmaceutical Industries and Association (EFPIA) report, 2018, an estimated US$ 48,111 million and US$ 82,418 million pharmaceutical expenditure was recorded in 2015 and 2016 respectively, in the U.S.
Increasing number of approvals for new molecule entities (NMEs) by regulatory agencies in this region is expected to bolster the market growth over the forecast period. In 2018, the U.S. Food and Drug Administration (FDA), approved 59 new molecule entities which enables new treatment options for patients and advances in health care for the American people.
Moreover, key players in the market are focused on collaboration activities for development of new kits and reagents used in detection of pyrogen in pharmaceutical products and devices. For instance, in May 2018, Merck and Solvias announced collaboration plans to develop PyroMAT System, a new kit for detection of pyrogen.
Key Players
Major players operating in the global pyrogen testing market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc., Charles River Laboratories Inc., GenScript, WuXi PharmaTech (Cayman), Inc., bioMérieux, Wako Chemicals USA, Inc., Sanquin, Ellab A/S, and Pyrostar
Pyrogen testing is detection of pyrogen in pharmaceutical drugs and devices. The contaminated devices or drugs when introduced in body can cause fever, shock, inflammation, and other problems. Pyrogen testing consists of kits, reagents, and instruments, which enables pyrogen and endotoxins detection by in-vitro methods and minimizes the usage of animal testing.
Market Dynamics
Increasing research and development in the field of pyrogen testing and advancements in technology for detection of endotoxin is a major factor driving pyrogen testing market growth. According to the Pharma R&D Annual Review, 2018, an estimated drug count in 2017 was around 14,872, while in 2018 it was around 15,267, resulting in an overall pipeline growth by 2.7% in 2018. Stringent government regulations and rising focus on in-vitro testing for detection of pyrogen is one of the major factors boosting growth of the market. For instance, in June 2012, the U.S. Food and Drug Administration (FDA) provided guidelines for pyrogen and endotoxin testing to industries.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 23 market data tables and 26 figures on "Pyrogen Testing Market - Global forecast to 2026”.
Asia Pacific Intelligence Center (India): 